Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Proceedings of the National Academy of Sciences of the United States of America

Serological rapid diagnostic tests (RDTs) are widely used across pathologies, often providing users a simple, binary result (positive or negative) in as little as 5 to 20 min. Since the beginning of the COVID-19 pandemic, new RDTs for identifying SARS-CoV-2 have rapidly proliferated. However, these seemingly easy-to-read tests can be highly subjective, and interpretations of the visible "bands" of color that appear (or not) in a test window may vary between users, test models, and brands. We developed and evaluated the accuracy/performance of a smartphone application (xRCovid) that uses machine learning to classify SARS-CoV-2 serological RDT results and reduce reading ambiguities. Across 11 COVID-19 RDT models, the app yielded 99.3% precision compared to reading by eye. Using the app replaces the uncertainty from visual RDT interpretation with a smaller uncertainty of the image classifier, thereby increasing confidence of clinicians and laboratory staff when using RDTs, and creating opportunities for patient self-testing.

Mendels David-A, Dortet Laurent, Emeraud C├ęcile, Oueslati Saoussen, Girlich Delphine, Ronat Jean-Baptiste, Bernabeu Sandrine, Bahi Silvestre, Atkinson Gary J H, Naas Thierry


SARS-CoV-2, machine learning, smartphone application